Immediate Impact

4 from Science/Nature 50 standout
Sub-graph 1 of 24

Citing Papers

Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
2024 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
2 intermediate papers

Works of J Janssen being referenced

Prophylaxis of Irinotecan-Induced Diarrhea with Neomycin and Potential Role for UGT1A1*28 Genotype Screening: A Double-Blind, Randomized, Placebo-Controlled Study
2006
Phase II to III Study Comparing Doxorubicin and Docetaxel With Fluorouracil, Doxorubicin, and Cyclophosphamide As First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre
2005

Author Peers

Author Last Decade Papers Cites
J Janssen 179 106 80 14 324
Rundles Rw 53 74 101 13 327
Kazutaka Takagi 114 66 212 24 352
Daniel Nguyen 87 47 142 20 310
Alberto Arcediano 226 25 49 15 334
M. Essink 88 39 64 11 314
Katjana Schwab 133 37 70 22 268
M Vigier 146 143 31 12 318
Kevin Imrie 140 85 51 16 328
C. Hans Keysser 55 48 71 16 335
Jiann-Shiuh Chen 51 117 94 23 346

All Works

Loading papers...

Rankless by CCL
2026